Efficacy, Immunogenicity and Safety of Inactivated Vaccine (Coronavac) Against SARS-COV2 in Children and Adolescents

NCT05225285 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1120

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Inactivated Coronavac/Butantan vaccine
BIOLOGICAL: BNT162b2 (Pfizer)

Sponsor

Federal University of Espirito Santo

Collaborators

[object Object]
[object Object]
[object Object]